Demant A/S (WILYY)

Healthcare
Medical Devices
Denmark
Yahoo Finance  •  Trading View  •  Company site
Price
$14.87
▼ -0.06 (-0.40%)
Market Cap
$6,553,037,312
Shares: 421,797,218
P/E
N/A
P/B: N/A
ROE
N/A
Current Ratio: N/A
Fundamentals Score
14 (NEGATIVE)

Company Overview

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Headquarters: Kongebakken 9, Smørum, 2765, Denmark  |  Employees: 23450  |  Website: demant.com
Key Contacts
IR / Phone: 45 39 17 73 00
Exchange: PNK
Industry: Medical Devices
Quick Financial Snapshot
RevenueN/A
Net IncomeN/A
Free Cash FlowN/A
Book Value / ShareN/A

Balance Sheet & Liquidity

Total LiabilitiesN/A
Total EquityN/A
Debt / EquityN/A
Current RatioN/A
Interest CoverageN/A
Working CapitalN/A

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)N/A
Industry P/EN/A
Forward P/EN/A
P/BN/A
Price / SalesN/A
P / FCFN/A
EV / EBITDAN/A
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROIC N/A
Asset Turnover N/A

Automated Fundamental Signals (Score: 14)

Passed
  • Price CAGR 5.66%
Failed
  • Positive Free Cash Flow
  • DCF valuation (undefined)

Price Chart (Candlestick)

Technical Analysis (Score: 60)

RSI (14)20.15
SMA 5016.55
SMA 20018.50
MACD-0.45
Signal NEUTRAL
RSI 20.1, SMA trend bearish, momentum -17.3%.

Governance & Management

Governance scores: Audit: N/A | Board: N/A | Compensation: N/A | Shareholder Rights: N/A
Executive Team
NameTitle
Mr. Søren Nielsen CEO, President & Member of Executive Board (1970)
Mr. René Schneider M.Sc CFO, President of Group Services & Member of Executive Board (1973)
Mr. Niels Wagner President of Hearing Care & Member of Executive Board (1971)
Sara Munch Andersen Head of Group Privacy & Compliance (—)
Stine Brandenhof Group General Counsel (—)
Ms. Trine Kromann-Mikkelsen Vice President of Corporate Communication and Sustainability (—)
Mr. Peter Pudselykke Head of Investor Relations (Leave of Absence) (—)
Ms. Anne-Karen Hunt President of Diagnostics Business Area (1977)
Governance data last updated: N/A

Latest News

No news available for this company.

← Back